AI assistant
Sending…
CLOROX CO /DE/ — Director's Dealing 2015
Jan 7, 2015
30403_dirs_2015-01-07_db366e5d-2cdf-405a-8d1a-d5261534b7e4.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: CLOROX CO /DE/ (CLX)
CIK: 0000021076
Period of Report: 2015-01-05
Reporting Person: GARNER DENISE (SVP - Chief Innovation Officer)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 1083.0000 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $66.4800 | 2020-09-14 | Common Stock (1995.0000) | Direct | |
| Stock Option (Right to Buy) | $68.1500 | 2021-09-13 | Common Stock (3060.0000) | Direct | |
| Stock Option (Right to Buy) | $72.1100 | 2022-09-11 | Common Stock (8700.0000) | Direct | |
| Stock Option (Right to Buy) | $84.4500 | 2023-09-17 | Common Stock (6730.0000) | Direct | |
| Stock Option (Right to Buy) | $89.8200 | 2024-09-17 | Common Stock (7080.0000) | Direct |
Footnotes
F1: Option vests in 4 equal installments - 1/4 on each of the first, second, third and fourth anniversaries of the grant date.
More from CLOROX CO /DE/
Regulatory Filings
2026
Jun 1
Board/Management Information
2026
May 28
Capital/Financing Update
2026
May 11
Regulatory Filings
2026
May 8
Capital/Financing Update
2026
May 6
Capital/Financing Update
2026
May 6
Capital/Financing Update
2026
May 1
Interim / Quarterly Report
2026
Apr 30
Regulatory Filings
2026
Apr 30
Major Shareholding Notification
2026
Apr 29